In addition, Tregs in the BM of CML mice had an activated effector phenotype (eTregs) compared with controls, as indicated by an increased expression of CD44 and lack of CD62L expression on the cell surface (Figure 1K). The gene discussed is CD44; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.